Literature DB >> 14607911

Polymorphonuclear granulocytes induce antibody-dependent apoptosis in human breast cancer cells.

Bernhard Stockmeyer1, Thomas Beyer, Winfried Neuhuber, Roland Repp, Joachim R Kalden, Thomas Valerius, Martin Herrmann.   

Abstract

Recent studies in HER-2/neu-targeted immunotherapy demonstrated that polymorphonuclear neutrophils (PMN) mediated Ab-dependent cellular cytotoxicity against HER-2/neu-positive breast cancer cell lines. However, the mechanism of cell death remained unclear. We used several assays to analyze the induction of apoptosis in the breast cancer cell line SK-BR-3 via PMN-dependent Ab-dependent cellular cytotoxicity. In the presence of the HER-2/neu Ab 520C9 and PMN from healthy donors, apoptosis occurred as detected by annexin V binding and disappearance of euploid SK-BR-3 nuclei, which can be differentiated from PMN nuclei by their increased DNA contents. Apoptosis induction was observed with E:T cell ratios as low as 10:1. Laser scanning fluorescence microscopy of TUNEL tumor cells or staining for cleaved cytokeratin-18 further confirmed apoptosis of the SK-BR-3 breast cancer cells. Killing via 520C9 was dependent on the interaction with FcR on PMN, because 1) F(ab')(2) fragments of 520C9 mediated no cytotoxicity, 2) target cell death was influenced by a biallelic polymorphism of FcgammaRIIa on the effector cells, and 3) a bispecific Ab against HER-2/neu and the IgA receptor (FcalphaRI) expressed on effector cells significantly induced apoptosis. Thus, PMN induce Ab-dependent apoptosis against human breast cancer cells targeted with HER-2/neu-directed mAbs or FcR directed bispecific Abs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607911     DOI: 10.4049/jimmunol.171.10.5124

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  22 in total

1.  Mac-1 promotes FcgammaRIIA-dependent cell spreading and migration on immune complexes.

Authors:  Ying Xiong; Chunzhang Cao; Alexandra Makarova; Brad Hyman; Li Zhang
Journal:  Biochemistry       Date:  2006-07-25       Impact factor: 3.162

Review 2.  Neutrophils in the tumor microenvironment: trying to heal the wound that cannot heal.

Authors:  Kelly L Singel; Brahm H Segal
Journal:  Immunol Rev       Date:  2016-09       Impact factor: 12.988

3.  Calicum microdomains form within neutrophils at the neutrophil-tumor cell synapse: role in antibody-dependent target cell apoptosis.

Authors:  Andrea J Clark; Michelle Diamond; Megan Elfline; Howard R Petty
Journal:  Cancer Immunol Immunother       Date:  2009-07-11       Impact factor: 6.968

4.  Systemic delivery of Salmonella typhimurium transformed with IDO shRNA enhances intratumoral vector colonization and suppresses tumor growth.

Authors:  Céline A Blache; Edwin R Manuel; Teodora I Kaltcheva; Andrea N Wong; Joshua D I Ellenhorn; Bruce R Blazar; Don J Diamond
Journal:  Cancer Res       Date:  2012-10-22       Impact factor: 12.701

5.  C-type lectin-like molecule-1 (CLL1)-targeted TRAIL augments the tumoricidal activity of granulocytes and potentiates therapeutic antibody-dependent cell-mediated cytotoxicity.

Authors:  Valerie R Wiersma; Marco de Bruyn; Ce Shi; Marloes J M Gooden; Maartje C A Wouters; Douwe F Samplonius; Djoke Hendriks; Hans W Nijman; Yunwei Wei; Jin Zhou; Wijnand Helfrich; Edwin Bremer
Journal:  MAbs       Date:  2015       Impact factor: 5.857

6.  Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients.

Authors:  Raphaël Maréchal; Jef De Schutter; Nathalie Nagy; Pieter Demetter; Arnaud Lemmers; Jacques Devière; Isabelle Salmon; Sabine Tejpar; Jean-Luc Van Laethem
Journal:  BMC Cancer       Date:  2010-06-30       Impact factor: 4.430

Review 7.  Lessons learnt from the Tasmanian devil facial tumour regarding immune function in cancer.

Authors:  Emma Peel; Katherine Belov
Journal:  Mamm Genome       Date:  2018-09-17       Impact factor: 2.957

8.  In vitro elimination of epidermal growth factor receptor-overexpressing cancer cells by CD32A-chimeric receptor T cells in combination with cetuximab or panitumumab.

Authors:  Sara Caratelli; Roberto Arriga; Tommaso Sconocchia; Alessio Ottaviani; Giulia Lanzilli; Donatella Pastore; Carlo Cenciarelli; Adriano Venditti; Maria Ilaria Del Principe; Davide Lauro; Elisa Landoni; Hongwei Du; Barbara Savoldo; Soldano Ferrone; Gianpietro Dotti; Giuseppe Sconocchia
Journal:  Int J Cancer       Date:  2019-10-12       Impact factor: 7.396

9.  Natural killer cell mediated cytotoxic responses in the Tasmanian devil.

Authors:  Gabriella K Brown; Alexandre Kreiss; A Bruce Lyons; Gregory M Woods
Journal:  PLoS One       Date:  2011-09-21       Impact factor: 3.240

10.  Mechanisms of action of CD20 antibodies.

Authors:  Peter Boross; Jeanette H W Leusen
Journal:  Am J Cancer Res       Date:  2012-11-20       Impact factor: 6.166

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.